Amenorrhoea https://greenmedinfo.com/taxonomy/term/656/all en Black Soybean has the potential to improve secondary amenorrhea https://greenmedinfo.com/article/black-soybean-has-potential-improve-secondary-amenorrhea PMID:  J Med Food. 2005 Winter;8(4):550-1. PMID: 16379571 Abstract Title:  The effect of soybeans on the anovulatory cycle. Abstract:  Full Citation: &quot;We treated 36 outpatients, suffering from secondary amenorrhea, who had no menstruation or no ovulation for more than 6 months before consulting our clinic. After polycystic ovary syndrome, hyperprolactinemia, and other ovarian disorders that require medical treatment had been ruled out through smear test examinations of the uterine cervix and uterine myoma, ovarian tumor, and endometriosis had been checked for with ultrasonography and serum CA-125, the subjects began to take 6 g/day of black soybean in micropowder form for 6 months (S group). We estimated the ovular improvement of theses patients, observing basal body temperature (BBT) and follicular development with ultrasonography during the menstrual cycle as the indexes for ovulation and compared them with 34 patients with no treatment (C group). In the S group, improved ovulation was seen in 12 patients, four patients became pregnant, and three patients had anovular menstruation within 3 months after starting to take soybean powder. The periods of first ovulation were 66 +/- 12 days. After ovulation started, all subjects had regular menstruations and ovulation, with more than a 7-day high phase in BBT. On the other hand, in the C group, improved ovulation was seen in two patients, and two patients had anovular menstruation. In conclusion, black soybean has the potential to improve the anovular menstrual cycle.&quot; https://greenmedinfo.com/article/black-soybean-has-potential-improve-secondary-amenorrhea#comments Amenorrhoea Mon, 20 Apr 2009 06:14:31 +0000 greenmedinfo 42719 at https://greenmedinfo.com Tamoxifen was a risk factor for chemotherapy-induced amenorrhea. https://greenmedinfo.com/article/tamoxifen-was-risk-factor-chemotherapy-induced-amenorrhea PMID:  Acta Oncol. 2016 Jun ;55(6):664-70. Epub 2016 Apr 22. PMID: 27105082 Abstract Title:  Risk of chemotherapy-induced amenorrhea in patients with breast cancer: a systematic review and meta-analysis. Abstract:  BACKGROUND: The aim of the study was to calculate the rate of chemotherapy-induced amenorrhea (CIA) after treatment with different adjuvant therapies in patients with breast cancer and to evaluate the risk factors for CIA based on the quality of evidence.PATIENT AND METHODS: A search of PubMed and ISI Web of Science was performed. All published trials with female breast cancer patients who received adjuvant chemotherapy and presented data on the rate of CIA were considered eligible. The pooled rates of CIA were calculated by random effects model. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each potential risk factor for CIA by using the generic inverse weighted method.RESULTS: We identified 580 potentially relevant studies, of which 75 were included in the analysis. Among 75 eligible studies, 19 different definitions of CIA have been used. The pooled rate of CIA was 55% (95% CI 50-60%) including 23 673 patients from 74 studies. The rate of CIA was increased by age with an estimate of 26% (95% CI 12-43%), 39% (95% CI 31-58%), and 77% (95% CI 71-83%) for women 40 years old, respectively. Two risk factors were associated with the occurrence of CIA and were supported by strong level of evidence: older age (&gt;40 years old), and the use of tamoxifen.CONCLUSIONS: This meta-analysis summarized the updated evidence on the impact of different adjuvant treatment regimens for breast cancer in menstruation and could serve as a helpful guide for oncologists during the discussion with their patients on fertility issues before decision on adjuvant therapy is made. A uniform definition of CIA is essential in future studies to make the interpretation of results more reliable. <p><a href="https://greenmedinfo.com/article/tamoxifen-was-risk-factor-chemotherapy-induced-amenorrhea" target="_blank">read more</a></p> https://greenmedinfo.com/article/tamoxifen-was-risk-factor-chemotherapy-induced-amenorrhea#comments Amenorrhoea Chemotherapy-Induced Toxicity: Tamoxifen Tamoxifen Meta Analysis Risk Factors Review Fri, 21 Apr 2017 15:50:42 +0000 greenmedinfo 146626 at https://greenmedinfo.com